Hiroyuki Kagechika
University of Tokyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hiroyuki Kagechika.
Journal of Cancer Research and Clinical Oncology | 1995
Yuichi Hashimoto; Hiroyuki Kagechika; Emiko Kawachi; Hiroshi Fukasawa; Go Saito; Koichi Shudo
Retinoids, including all-trans-retinoic acid, its isomers, and fifty synthetic retinoids (retinobenzoic acids), were tested for differentiation-inducing activity on human leukemia cell lines HL-60 and NB4. A good linear correlation, with anr value of 0.91, between the ED50 values for the differentiation-inducing activity towards HL-60 cells and that towards NB4 cells was found.
Biochemical and Biophysical Research Communications | 1992
Youko Matsushima; Emiko Kawachi; Hideo Tanaka; Hiroyuki Kagechika; Yuichi Hashimoto; Koichi Shudo
Retinoidal activity of retinoic acid isomers [all-trans-retinoic acid (ATRA), 9-cis-retinoic acid (9CRA) and 13-cis-retinoic acid (13CRA)] and their oxidized derivatives [19-hydroxy and 19-oxo derivatives of ATRA (19-hydroxy-ATRA and 19-oxo-ATRA), 19-oxo derivative of 9CRA (19-oxo-9CRA), and 19-hydroxy derivative of 13CRA (19-hydroxy-13CRA)] was evaluated by means of a human promyelocytic leukemia HL-60 cell differentiation induction assay. All the compounds examined showed this activity with ED50 values of 2-30 nM, which are in accordance with their binding activity to nuclear retinoic acid receptors (RARs).
Biochemical and Biophysical Research Communications | 1991
Rumiko Shimazawa; Rie Sanda; Hidetoshi Mizoguchi; Yuichi Hashimoto; Shigeo Iwasaki; Hideo Tanaka; Hiroyuki Kagechika; Koichi Shudo
A fluorescent probe for retinoid receptors (RARs) was designed and prepared. The probe consists of a retinoid moiety and a dansyl moiety, i.e., 2-[3-(5-dimethylaminonaphthalene-1-sulfonyl)- aminopropyl-1-oxy]-4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2- naphthalenyl)carboxamido]benzoic acid: DAM-3. DAM-3 specifically bound RARs. Additionally, a photoreactive RAR fluorescent probe was designed and prepared, i.e., 2-[3-(5-azidonaphthalene- 1-sulfonyl)aminopropyl-1-oxy]-4-[(5,6,7,8-tetrahydro-5,5,8,8- tetramethyl-2-naphthalenyl)carboxamido]benzoic acid (ADAM-3). ADAM-3 irreversibly and specifically bound RARs using ultraviolet irradiation.
Journal of the American Chemical Society | 1991
Kentaro Yamaguchi; Go Matsumura; Hiroyuki Kagechika; Isao Azumaya; Yuji Ito; Akiko Itai; Koichi Shudo
Journal of the American Chemical Society | 1995
Isao Azumaya; Kentaro Yamaguchi; Iwao Okamoto; Hiroyuki Kagechika; Koichi Shudo
Journal of Medicinal Chemistry | 1994
Laurence Eyrolles; Hiroyuki Kagechika; Emiko Kawachi; Hiroshi Fukasawa; Tohru Iijima; Youko Matsushima; Yuichi Hashimoto; Koichi Shudo
Chemical & Pharmaceutical Bulletin | 1995
Hideo Shimasaki; Hiroyuki Kagechika; Hiroshi Fukasawa; Emiko Kawachi; Koichi Shudo
Journal of Medicinal Chemistry | 1992
Hideo Tanaka; Hiroyuki Kagechika; Emiko Kawachi; Hiroshi Fukasawa; Yuichi Hashimoto; Koichi Shudo
Chemical & Pharmaceutical Bulletin | 1994
Laurence Eyrolles; Emiko Kawachi; Hiroyuki Kagechika; Yuichi Hashimoto; Koichi Shudo
Biochemical and Biophysical Research Communications | 1995
O. Nakajima; Hiroyuki Kagechika; Koichi Shudo; Yuichi Hashimoto; Shigeo Iwasaki